Clinical Trial Update: A Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for PDC-1421 in adults with ADHD; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• PDC-1421

Snippet

Sponsor: BioLite, Inc. | Conditions: Attention-Deficit Hyperactivity Disorder (ADHD) | Phase 2 | Status: COMPLETED | Results posted: 2021-11-05